India

AstraZeneca employees fight layoffs in India as drugmaker shifts 'strategic priorities'
AstraZeneca employees fight layoffs in India as drugmaker shifts 'strategic priorities'
Fierce Pharma
AstraZeneca
layoffs
India
Flag link:
Bristol Myers expands footprint in India with drug development and IT center
Bristol Myers expands footprint in India with drug development and IT center
Endpoints
Bristol Myers Squibb
India
drug development
IT
Flag link:
New competitors push Sanofi to offer voluntary retirement packages at two Indian sites
New competitors push Sanofi to offer voluntary retirement packages at two Indian sites
Endpoints
Sanofi
India
drug manufacturing
Flag link:
FDA halts imports of several Sun Pharma drugs made in India due to outstanding quality issues
FDA halts imports of several Sun Pharma drugs made in India due to outstanding quality issues
Endpoints
Sun Pharma
India
FDA
drug importation
Flag link:
GSK to slash about 150 consumer commercial jobs in India
GSK to slash about 150 consumer commercial jobs in India
Fierce Pharma
GSK
India
layoffs
Flag link:
Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization
Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization
Fierce Pharma
Ocugen
vaccines
COVID-19
intranasal vaccines
Europe
Japan
India
Flag link:
Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO
Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO
Endpoints
Europe
India
CROs
generics
Flag link:
After Big Pharma pulls back in Russia, Dr. Reddy's says business is booming
After Big Pharma pulls back in Russia, Dr. Reddy's says business is booming
Fierce Pharma
Russia
Ukraine
India
Dr Reddy's
Flag link:
Pfizer rolls out voluntary retirement scheme in India as it dives deeper into digital
Pfizer rolls out voluntary retirement scheme in India as it dives deeper into digital
Fierce Pharma
Pfizer
India
digital pharma
voluntary retirement scheme
Flag link:
A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
Endpoints
vaccines
COVID-19
intellectual property
Europe
India
South Africa
World Trade Organiztion
Flag link:
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
India's hesitance to condemn Russia puts the country's pharma industry in compromising position
Fierce Pharma
Russia
Ukraine
India
Cipla
Dr Reddy's
Torrent Pharmaceuticals
Sun Pharma
Flag link:
Biocon buys Viatris biosimilars for $3.3bn, eyes IPO
Biocon buys Viatris biosimilars for $3.3bn, eyes IPO
Pharmaforum
Biocon
India
Viatris
Mylan
biosimilars
M&A
Flag link:
Citing migraine drug growth and pandemic, Lundbeck to cut 300 jobs and close India facility
Citing migraine drug growth and pandemic, Lundbeck to cut 300 jobs and close India facility
Endpoints
Lundbeck
R&D
layoffs
Vyepti
migraines
India
Flag link:
India approves J&J’s single-dose Covid-19 vaccine for emergency use
India approves J&J’s single-dose Covid-19 vaccine for emergency use
Pharmaceutical Business Review
JNJ
vaccines
COVID-19
India
Flag link:
Zydus Cadila nears world-first human plasmid DNA vaccine approval
Zydus Cadila nears world-first human plasmid DNA vaccine approval
Pharmaforum
Zydus Cadila
India
plasmid DNA
vaccines
COVID-19
Flag link:
How Big Is Pfizer's Vaccine Opportunity in India?
How Big Is Pfizer's Vaccine Opportunity in India?
Motley Fool
Pfizer
BioNTech
vaccines
COVID-19
India
Flag link:
Eli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib
Eli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib
Fierce Pharma
Eli Lilly
baricitinib
India
drug manufacturing
COVID-19
Flag link:
Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak
Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak
Fierce Pharma
Gilead Sciences
Merck
India
COVID-19
Flag link:
India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports
India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports
Fierce Pharma
India
drug manufacturing
Gilead Sciences
remdesivir
COVID-19
Flag link:
U.S. focus on Pfizer production could delay manufacturing of other COVID-19 vaccines, Serum Institute CEO warns
U.S. focus on Pfizer production could delay manufacturing of other COVID-19 vaccines, Serum Institute CEO warns
Fierce Pharma
Pfizer
Serum Institute
India
COVID-19
vaccines
Flag link:

Pages